首页> 外文期刊>Urologic oncology >Urethral recurrence in patients following orthotopic urinary diversion Hassan JM, Cookson MS, Smith JA Jr, Chasubng SS, Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN.
【24h】

Urethral recurrence in patients following orthotopic urinary diversion Hassan JM, Cookson MS, Smith JA Jr, Chasubng SS, Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN.

机译:田纳西州纳什维尔范德比尔特大学医学中心泌尿外科的原位尿流改道术后患者的尿道复发Hassan JM,Cookson MS,Smith JA Jr,Chasubng SS。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: We present our experience with urethral recurrence of transitional cell carcinoma following cystectomy and orthotopic urinary diversion in a contemporary series. MATERIALS AND METHODS: Between June 1995 and December 2001, 415 patients underwent radical cystectomy for transitional cell carcinoma. Of those patients 196 (47.2%) received an orthotopic urinary diversion. Demographics, clinical characteristics, pathological stage and patient outcomes were reviewed. RESULTS: Mean followup was 34.1 months (range 0.3 to 97.3). Of the 196 patients who underwent orthotopic diversion 59 (30.1%) had T3 or greater disease on final pathological evaluation. Thirteen patients (6.6%) were found to have prostatic urethral involvement while 83 (42.3%) had elements of carcinoma in situ. No patient with prostatic urethral involvement had subsequent urethral recurrence. Overall only 1 patient (0.5%) had urethral recurrence of transitional cell carcinoma following orthotopic urinary diversion. The urethral recurrencerate in patients with orthotopic diversion was less than in patients with ileal conduit creation during the same period (2.1%). The overall disease recurrence rate following orthotopic diversion was 31.6% (62 of 196). CONCLUSIONS: Urethral recurrence following orthotopic neobladder was rare in this series despite using selection criteria that were less stringent than those of other comparable series. Overall disease recurrence was relatively high in patients with high risk pathological features but urethral recurrence in this group with orthotopic urinary diversion remained low.
机译:目的:我们在当代系列中介绍膀胱切除术和原位尿路改道后移行细胞癌尿道复发的经验。材料与方法:1995年6月至2001年12月,对415例行移行细胞癌的患者行根治性膀胱切除术。在这些患者中,有196名(47.2%)接受了原位尿路改道。人口统计学,临床特征,病理分期和患者预后进行了回顾。结果:平均随访时间为34.1个月(范围0.3至97.3)。在进行原位转移的196例患者中,根据最终病理评估,有59例(30.1%)患有T3或更大病。发现有13例(6.6%)患前列腺尿道受累,而83例(42.3%)有原位癌。没有前列腺尿道受累的患者随后发生尿道复发。总体上只有1例患者(0.5%)在原位尿流改道后发生了移行细胞癌的尿道复发。在同一时期,原位转移患者的尿道复发率低于回肠导管形成患者(2.1%)。原位转移后的总体疾病复发率为31.6%(196个中的62个)。结论:尽管使用的选择标准不如其他类似系列严格,但原位新膀胱术后尿道复发很少见。具有高风险病理特征的患者的总体疾病复发率较高,但是该组原位尿流转移的尿道复发率仍然较低。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号